Broad Spectrum ?29 Apr 2023 18:45
Can someone explain how Sng001 will ever be approved as such without conducting multiple P3trials ? Or, will Synairgen complete a single P3 for a virus and then seek EUA as a repurposed drug for any new/old viruses supported by in vitro results ? The term " Broad Spectrum" seems unachievable unless conducted by BP at considerable expense ,and over many many years . This also questions why AZ abandoned us during the asthma research, when if they were aware of the possible "Broad Spectum" possibilities, they didn't persist with R&D into the other bronchial viruses ? Then again TFG must have done their due diligence into the drugs potential so why commit so heavily?
Or was this a catastrophic mistake by a team or individual who got sucked in on the reported success rates of P3 trials for this type of respitory drug ?
Did we all miss something that AZ didn't ?? After all ,as far as I'm aware ,they've never attempted to come back to the table even though Marsden said they wouldn't entertain an offer / help after " doing all the heavy work" or something similar .